Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure [Phase 4]
Phase 4 clinical trial update for valsartan in early stage heart failure and hypertension.
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil [Phase 3]
Phase 3 trial update for VALORY study assessing valsartan/hydrochlorizide in patients with hypertension who do not respond to olmesartan med…
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: Gut Butyrate and Blood Pressure in African Americans [Phase 1]
Phase 1 trial investigating gut butyrate effects on blood pressure in African Americans with hypertension completed with results posted.
-
FDA approval · 2023-10-17FDA Approved: GUANFACINE — Original Application (Advagen Pharma Ltd)
FDA approves Advagen Pharma Ltd's generic guanfacine as an approved product under ANDA 216762, confirming it as a generic version of guanfac…
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: Mechanism of Hypertension Treatments in Liver Transplant Recipients (BLOCK LTR-HTN) [Phase 4]
Phase 4 clinical trial evaluating mechanisms of hypertension treatments in liver transplant recipients has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension. [Phase 3]
Phase 3 trial evaluating safety and efficacy of valsartan/amlodipine combination and monotherapy in patients with hypertension.
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension [Phase 3]
A phase 3 trial evaluating the safety of the combination of valsartan and amlodipine in hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Hypertension and Cardiovascular Risk Factors [Phase 4]
Phase 4 clinical trial update related to hypertension and cardiovascular risk factors completed.
-
FDA approval · 2023-10-10FDA Approved: SPIRONOLACTONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for spironolactone by Mylan Pharmaceuticals Inc., updating the approval for this generic diuretic. T…
-
FDA approval · 2023-10-06FDA Approved: HYDRALAZINE HYDROCHLORIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for Hydralazine Hydrochloride (generic) from Heritage Pharmaceuticals (d/b/a Avet Pharmaceutical…
-
FDA approval · 2023-10-05FDA Approved: GUANFACINE — Original Application (A2A Integrated Pharmaceuticals)
FDA approved the original application for guanfacine from A2A Integrated Pharmaceuticals, enabling generic guanfacine products to enter the …
-
CLINICAL_TRIALS trial_result · 2023-10-05Clinical Trial Update: Southeastern Collaboration to Improve Blood Pressure Control [NA]
A completed clinical trial investigating blood pressure control sponsored by the University of Alabama at Birmingham; results posted in 2023…
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: TARGET BP I Clinical Trial [Phase 3]
Phase 3 clinical trial update for TARGET BP I investigating hypertension; status ACTIVE_NOT_RECRUITING.
-
FDA approval · 2023-09-29FDA Approved: AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a generic fixed-dose combination tablet containing amlodipine, valsartan, and hydrochlorothi…
-
FDA approval · 2023-09-29FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved Granules Pharmaceuticals' generic fixed-dose combination tablet of losartan potassium and hydrochlorothiazide for the treatment…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: The Peregrine Post-Market Study for the Treatment of Hypertension [NA]
Post-market study completed for a hypertension treatment; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: SMS System for Patients With Uncontrolled Hypertension [NA]
A completed clinical trial evaluating an SMS system to support patients with uncontrolled hypertension; results posted in 2023.
-
FDA approval · 2023-09-27FDA Approved: CLONIDINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for clonidine from Mylan Pharmaceuticals Inc., authorizing a generic clonidine product under an …
-
FDA approval · 2023-09-26FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for metoprolol succinate from Nivagen Pharmaceuticals, Inc., authorizing changes to the product'…
-
FDA approval · 2023-09-26FDA Approved: DOXAZOSIN — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for doxazosin from Accord Healthcare Inc., indicating an update to the approved generic product unde…
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: A Study to Evaluate Efficacy and Safety of HCP1803 in Patients With Essential Hypertension [Phase 3]
Phase 3 trial update evaluating HCP1803 for efficacy and safety in essential hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-25Clinical Trial Update: Clinical Study of UMOD NKCC2 Interaction on Salt-sensitivity in Hypertension [Phase 4]
Phase 4 clinical trial update evaluating UMOD NKCC2 interaction on salt-sensitivity in hypertension has been completed.
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension [Phase 2]
Phase 2 trial evaluating the efficacy and safety of a quadruple ultra-low-dose treatment for hypertension; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients [Phase 3]
Phase 3 trial results evaluating the efficacy and safety of HCP1904-3 in essential hypertension have been completed.
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients [Phase 3]
Phase 3 trial evaluating the efficacy and safety of HCP1904-1 in essential hypertension has completed.